Drug Repurposing
Hoton da AI ya samar
Experts flag shingles vaccine, sildenafil and riluzole as leading Alzheimer’s repurposing candidates
An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya
A University of Exeter-led study funded by Alzheimer’s Society has identified three already-approved medicines—the shingles vaccine Zostavax, sildenafil (Viagra) and riluzole—as top “priority” candidates to be tested in clinical trials for Alzheimer’s disease, after a structured review of 80 existing drugs by an international expert panel.